Immunobiology of bone marrow transplantation as treatment for hematologic malignancies
Champlin, R.
Transplantation Proceedings 23(4): 2123-2127
1991
ISSN/ISBN: 0041-1345 PMID: 1871828 Document Number: 373930
In conclusion, graft-versus-leukemia is important to prevent leukemia relapse following allogeneic bone marrow transplantation. This beneficial GVL effect is at least partly mediated by T-lymphocytes and is greatest in transplants from HLA-nongenotypically identical donors. GVL is associated with the presence of GVHD, although preliminary studies suggest it may be possible to separate these two processes. Improvement in treatment results requires innovative effective therapies to enhance the direct antineoplastic effects of the preparative regimen or immune-mediated antileukemia mechanisms.
Document emailed within 1 workday
Related Documents
Takeyama, K.; Tobinai, K.; Shimoyama, M. 1992: High dose chemotherapy with autologous bone marrow transplantation and G-CSF for hematologic malignancies Nihon Rinsho. Japanese Journal of Clinical Medicine 50(6): 1414-1418Wu, D.P.; Milpied, N.; Moreau, P.; Mechinaud-Lacroix, F.; Mahe, B.; Le Tortorec, S.; Rapp, M.J.; Bourdin, S.; Mahe, J.M.; Harousseau, J.L. 1994: Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies Bone Marrow Transplantation 14(5): 751-757
Guillaume, T.; Sekhavat, M.; Rubinstein, D.B.; Hamdan, O.; Leblanc, P.; Symann, M.L. 1994: Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution Cancer Research 54(14): 3800-3807
Beatty, P.G. 1995: Bone marrow transplantation for the treatment of hematologic diseases: status in 1994 Experimental Hematology 23(3): 277-288
Barriga, F.; Bertín, P.; Baeza, R.; Pereira, J.; Schwartzmann, L.; Oliva, J.; Ocqueteau, M.; Sapunar, F.; Duhalde, M.; Lira, P. 1995: Allogenic bone marrow transplantation in the treatment of malignant hematologic disease Revista Medica de Chile 123(5): 605-611
Nachbaur, D.; Schwaighofer, H.; Thaler, J.; Weyrer, W.; Fink, M.; Nussbaumer, W.; Fritsch, E.; Niederwieser, D. 1994: Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors Wiener Klinische Wochenschrift 106(7): 201-207
Nemet, D. 1989: Autologous bone marrow transplantation--a new approach in the treatment of neoplastic hematologic diseases. I. Scientific principles and methodology of the treatment Lijecnicki Vjesnik 111(12): 466-474
Verdonck, L.F.; Vendrik, C.P.; Dekker, A.W.; van Kempen, M.L.; Schornagel, J.H.; Rozenberg-Arska, M.; de Gast, G.C. 1985: High dose cytotoxic agents followed by autologous bone marrow transplantation; treatment results in 25 patients with various malignancies Nederlands Tijdschrift Voor Geneeskunde 129(25): 1186-1190
Kaizer, H.; Wharam, M.D.; Munoz, L.L.; Johnson, R.J.; Elfenbein, G.J.; Tutschka, P.J.; Braine, H.G.; Santos, G.W.; Leventhal, B.G. 1979: Autologous bone marrow transplantation in the treatment of selected human malignancies: The Johns Hopkins Oncology Center Program Experimental Hematology 7 Suppl. 5: 309-320
Sanders, J.E. 1991: Endocrine problems in children after bone marrow transplant for hematologic malignancies. the Long-term Follow-up Team Bone Marrow Transplantation 8(Suppl 1): 2-4
Pejin, D.; Popović, S.; Dokić, M.; Felle, D.; Stefanović, N. 1990: Allogenic transplantation of bone marrow in hematologic diseases. Preparation and completion of transplantation at the Hematology Clinic in Novi Sad Acta Chirurgica Iugoslavica 37(Suppl 1): 11-15
Johnsen, H.E.; Birgens, H.; Hansen, N.E. 1991: Autologous bone marrow transplantation in malignant hematologic diseases Ugeskrift for Laeger 153(25): 1790-1793
Blume, K.G. 1993: A general overview of the status of bone marrow transplantation for hematologic diseases Leukemia 7(7): 1078-1079
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904
Nemet, D.; Labar, B.; Bogdanic, V.; Skodlar, J.; Petrovecki, M.; Mrsic, M.; Maravic, N.; Sneller, V.; Radman, I.; Kovacevic-Metelko, J. 1995: Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb Wiener Medizinische Wochenschrift 145(2-3): 61-64
De Rosa, L.; Montuoro, A.; Pandolfi, A.; Lanti, T.; Pescador, L.; Morara, R.; De Laurenzi, A. 1991: Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies Haematologica 76(Suppl 1): 37-40
Dimeo, F.; Bertz, H.; Finke, J.; Fetscher, S.; Mertelsmann, R.; Keul, J. 1996: An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation Bone Marrow Transplantation 18(6): 1157-1160
Stoppa, A.M.; Hirn, J.; Blaise, D.; Delaage, M.; Novakovitch, G.; Viens, P.; Capiello, M.A.; Mannoni, P.; Mawas, C.; Maraninchi, D. 1990: Autologous bone marrow transplantation for B cell malignancies after in vitro purging with floating immunobeads Bone Marrow Transplantation 6(5): 301-307
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Angelucci, E.; Polchi, P.; Lucarelli, G.; Galimberti, M.; Baronciani, D.; Giardini, C.; Durazzi, S.M.; Moretti, L.; Donati, M. 1989: Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide Haematologica 74(5): 455-461